Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission
暂无分享,去创建一个
R. Cone | T. Moench | Richard A Cone | Thomas R Moench | Timothy Hoen | T. Hoen | XiXi Wong | Raed Abusuwwa | Deborah J Anderson | XiXi Wong | Raed Abusuwwa
[1] D. Bernstein,et al. Evaluations of Unformulated and Formulated Dendrimer-Based Microbicide Candidates in Mouse and Guinea Pig Models of Genital Herpes , 2003, Antimicrobial Agents and Chemotherapy.
[2] M. Bowden,et al. Microbicides--evaluating multiple formulations of C31G. , 2002, Contraception.
[3] F. Krebs,et al. Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[4] R. Doms,et al. Use of a Small Molecule CCR5 Inhibitor in Macaques to Treat Simian Immunodeficiency Virus Infection or Prevent Simian–Human Immunodeficiency Virus Infection , 2003, The Journal of experimental medicine.
[5] K. Barnhart,et al. In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse. , 2004, Contraception.
[6] K. Barnhart,et al. Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse. , 2002, Contraception.
[7] K. Whaley,et al. Nonoxynol-9 protects mice against vaginal transmission of genital herpes infections. , 1993, The Journal of infectious diseases.
[8] P. Spear,et al. Disruption of Adherens Junctions Liberates Nectin-1 To Serve as Receptor for Herpes Simplex Virus and Pseudorabies Virus Entry , 2002, Journal of Virology.
[9] D. Phillips,et al. Nonoxynol-9 causes rapid exfoliation of sheets of rectal epithelium. , 2000, Contraception.
[10] A. Ashkar,et al. Progesterone Increases Susceptibility and Decreases Immune Responses to Genital Herpes Infection , 2003, Journal of Virology.
[11] S. Hillier,et al. The Vaginal Microflora of Pig‐Tailed Macaques and the Effects of Chlorhexidine and Benzalkonium on This Ecosystem , 1996, Sexually transmitted diseases.
[12] C. Lee. Review: in vitro spermicidal tests. , 1996, Contraception.
[13] D. Anderson,et al. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. , 2001, The Journal of infectious diseases.
[14] John P. Moore,et al. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120 , 2003, Nature Medicine.
[15] K. Barnhart,et al. Distribution of a spermicide containing Nonoxynol-9 in the vaginal canal and the upper female reproductive tract. , 2001, Human reproduction.
[16] D. Phillips,et al. Sulfated polysaccharides block chlamydia infection in vitro, but do not protect mice from vaginal inoculation. , 1998, Microbial pathogenesis.
[17] K. Whaley,et al. Residence half-life of IgG administered topically to the mouse vagina. , 1996, Biology of reproduction.
[18] Fred Hendrikse,et al. Monitoring of rabbit cornea response to dehydration stress by optical coherence tomography. , 2004, Investigative ophthalmology & visual science.
[19] H. Rees,et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial , 2002, The Lancet.
[20] S. Hillier,et al. Effects of Nonoxynol‐9 on Vaginal Microflora and Chlamydial Infection in a Monkey Model , 1996, Sexually transmitted diseases.
[21] P. Sen,et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model , 2001, AIDS.
[22] K. Barnhart,et al. Lesson learned and dispelled myths: three-dimensional imaging of the human vagina. , 2004, Fertility and sterility.
[23] G. Doncel,et al. In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. , 2005, AIDS research and human retroviruses.
[24] N. Padian,et al. Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices , 2001, AIDS.
[25] L. Stanberry,et al. Entry of Inflammatory Cells Into the Mouse Vagina Following Application of Candidate Microbicides: Comparison of Detergent-Based and Sulfated Polymer–Based Agents , 2002, Sexually transmitted diseases.
[26] A. Clegg,et al. The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in-vitro. , 1993, The Journal of antimicrobial chemotherapy.
[27] E. De Clercq,et al. Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[28] O. Laeyendecker,et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. , 2005, The Journal of infectious diseases.
[29] D. Phillips,et al. Nonoxynol-9 enhances rectal infection by herpes simplex virus in mice. , 1998, Contraception.
[30] D. Bernstein,et al. The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model. , 1999, The Journal of infectious diseases.
[31] F. Krebs,et al. Comparative Safety Evaluation of the Candidate Vaginal Microbicide C31G , 2005, Antimicrobial Agents and Chemotherapy.
[32] A. Iwasaki,et al. In Vivo Role of Nectin-1 in Entry of Herpes Simplex Virus Type 1 (HSV-1) and HSV-2 through the Vaginal Mucosa , 2004, Journal of Virology.
[33] F. Krebs,et al. Mouse Model of Cervicovaginal Toxicity and Inflammation for Preclinical Evaluation of Topical Vaginal Microbicides , 2004, Antimicrobial Agents and Chemotherapy.
[34] P. Spear,et al. Herpes simplex virus: receptors and ligands for cell entry , 2004, Cellular microbiology.
[35] K. Whaley,et al. Microbicide Efficacy and Toxicity Tests in a Mouse Model for Vaginal Transmission of Chlamydia trachomatis , 2002, Sexually transmitted diseases.
[36] K. Barnhart,et al. Disruption of the upper female reproductive tract epithelium by nonoxynol-9. , 2003, Contraception.
[37] E. Clercq,et al. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. , 1997, General pharmacology.
[38] F. Krebs,et al. A Broad-Spectrum Microbicide with Virucidal Activity against Sexually Transmitted Viruses , 1999, Antimicrobial Agents and Chemotherapy.
[39] G. Rutherford,et al. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men. , 2002, Cochrane Database of Systematic Reviews.
[40] M. Bajpai,et al. Interleukin (IL)-1, IL-6, and IL-8 Predict Mucosal Toxicity of Vaginal Microbicidal Contraceptives1 , 2004, Biology of reproduction.
[41] S. S. Olmsted,et al. Tests of BufferGel for Contraception and Prevention of Sexually Transmitted Diseases in Animal Models , 2001, Sexually transmitted diseases.
[42] E. Raymond,et al. Contraceptive Effectiveness and Safety of Five Nonoxynol-9 Spermicides: A Randomized Trial , 2004, Obstetrics and gynecology.
[43] T. Quinn,et al. The Effects of Herpes Simplex Virus-2 on HIV-1 Acquisition and Transmission: A Review of Two Overlapping Epidemics , 2004, Journal of acquired immune deficiency syndromes.
[44] K. Whaley,et al. Tests of vaginal microbicides in the mouse genital herpes model. , 1997, Contraception.
[45] N. Bourne,et al. Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[46] A. Gettie,et al. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. , 1998, AIDS research and human retroviruses.
[47] G. Dickinson,et al. Sensitivity testing of Pseudomonas aeruginosa to ciprofloxacin: comparison of the modified Stokes' method with MIC results obtained by the Etest. , 1999, The Journal of antimicrobial chemotherapy.
[48] Naomi Bergman,et al. Comparison of Microbicides for Efficacy in Protecting Mice Against Vaginal Challenge With Herpes Simplex Virus Type 2, Cytotoxicity, Antibacterial Properties, and Sperm Immobilization , 2001, Sexually transmitted diseases.
[49] F. Krebs,et al. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate. , 1999, Antiviral research.
[50] D. Phillips,et al. Lubricants containing N-9 may enhance rectal transmission of HIV and other STIs. , 2004, Contraception.
[51] K. Schneweis,et al. Pathogenesis of genital herpes simplex virus infection in mice , 1984, Medical Microbiology and Immunology.